Technical analysis of Immunome, Inc. (IMNM): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States.
Price Performance
| 1 month | -6.27% |
| 3 months | -23.24% |
| Year-to-date | -8.80% |
| 1 year | +15.24% |
| 3 years | +123.89% |
| 5 years | -13.47% |
52-Week Range
| 52-week High | $30.06 |
| 52-week Low | $14.64 |
| Avg Volume (90d) | 1.3M |
Technical Indicators
| SMA 50 | $22.26 |
| SMA 200 | $22.48 |
| Beta | 2.14 |
| 30-day Volatility (annualised) | 62.2% |
| Price vs SMA 50 | -12.0% |
| Price vs SMA 200 | -12.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $21.48 | |
| 2026-01 | $24.62 | +14.6% |
| 2026-02 | $21.86 | -11.2% |
| 2026-03 | $21.87 | +0.0% |
| 2026-04 | $22.94 | +4.9% |
| 2026-05 | $21.83 | -4.8% |
| 2026-06 | $21.19 | -2.9% |
| 2026-07 | $22.76 | +7.4% |
| 2026-08 | $27.41 | +20.4% |
| 2026-09 | $21.51 | -21.5% |
| 2026-10 | $18.21 | -15.3% |
| 2026-11 | $19.59 | +7.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-05 | $-0.60 | |
| 2026-08-11 | $-0.51 | |
| 2026-05-12 | $-0.60 | |
| 2026-03-03 | $-0.59 | |
| 2025-11-06 | $-0.57 | |
| 2025-08-06 | $-0.52 | |
| 2025-05-12 | $-0.66 | |
Price
| Price | $19.59 (closing price, November 2, 2026) |
| Market Cap | $2.3B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 4.23 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 15.08 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 21.61 |